Market participants remain wary of high rates of inflation and are expecting further rate hikes by the US Federal Reserve, which will push up the cost of borrowing and dampen corporate investments.Despite the upbeat performance, analysts tracking the global markets remain cautious over stocks over the management commentary and brokerage review over the select stocks.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.
May 25, 2026